Characteristics, treatment, and antiretroviral prophylaxis adherence of South African rape survivors

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):68-71. doi: 10.1097/QAI.0b013e31813e62f8.

Abstract

Objective: To assess the characteristics, treatment received, and adherence to antiretroviral prophylaxis among South African rape survivors.

Design: Record review of clients presenting to the Northdale Lifeline Rape Crisis Center between May 2003, and July 2004.

Outcome measures: Data on demographics, record of treatment received with antiretroviral prophylaxis, syndromic treatment for sexually transmitted infections, and emergency contraception were collected. Adherence to antiretroviral prophylaxis was defined by filling 4 weekly prescriptions for zidovudine and lamivudine. Results of follow-up HIV testing were recorded.

Results: A total of 390 records were reviewed. Ninety-five percent of clients accepted HIV testing at presentation, and HIV seroprevalence at presentation was 35.6%. Of the 233 clients testing HIV-negative, 198 (85%) received antiretroviral prophylaxis, 57% of whom were assessed as adherent. Only 55 clients (27.1%) returned for HIV testing at 6 weeks; 1 woman seroconverted.

Conclusions: Postrape care is an important service provided to South African women, and strategies should be developed to improve adherence to antiretroviral prophylaxis and follow-up testing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Retroviral Agents / administration & dosage*
  • Anti-Retroviral Agents / therapeutic use*
  • Child
  • Contraception, Postcoital
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Male
  • Middle Aged
  • Patient Compliance*
  • Rape* / psychology
  • South Africa
  • Survivors

Substances

  • Anti-Retroviral Agents